TNFSF8 and inflammatory bowel disease: CD30 expression on eosinophils in the colon was found to be a highly effective differentiating marker of UC versus CD in IBD patients [13], and studies have suggested that circulating monocytes from UC patients have elevated levels of CD30L [14,15].